Please assess the completion status of the following clinical trial:

Trial Title: Marcaine Use in Laparoscopic Gynecological Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* • Ages 18-50~  * BMI 20-35~ * Gynecologic ambulatory cases only~ * Total of 3 incisions, with left and right incisions both being 5mm-10mm in size~ * Not taking pain medications prior to surgery~ * Length of surgery up to 3 hours~ * PACU stay up to 6 hours~ * Willing and able to sign informed consent~Exclusion Criteria:~* • Age or BMI out of range~  * Surgery longer than 3 hours or PACU stay longer than 6 hours~ * patients with chronic pelvic pain~ * Oncologic cases~ * Pregnant patients

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Marcaine administered pre-incision. (Type: ACTIVE_COMPARATOR): Pre-operative administration, using both the specific drug - Marcaine 0.25%- and total amount - 5cc per incision.
- Marcaine administered post-incision (Type: ACTIVE_COMPARATOR): Marcaine 0.25% administered post-incision, total amount 5cc per incision.

Based on this trial design, predict the completion outcome and termination type (if applicable).